Phibro Animal Health to acquire Zoetis’ medicated feed additive portfolio for $350 million
Acquiring Company
Phibro Animal Health Corporation
Acquired Company
Zoetis
TeaneckParsippanyHealth CareAnimal FeedPetVeterinaryNutritionBiotechnologyHealth CareMedicalAnimal FeedPetVeterinaryDescription
Phibro Animal Health Corporation has entered into a definitive agreement to acquire Zoetis Inc.’s medicated feed additive (MFA) product portfolio, certain water soluble products, and related assets for $350 million. This strategic acquisition enables Phibro Animal Health to expand its global reach and broaden its product portfolio, reinforcing the company’s commitment to delivering value to its customers and shareholders.
Quick answer
Phibro Animal Health Corporation is acquiring Zoetis for $350 million, announced April 28, 2024. Phibro Animal Health Corporation is based in Teaneck, New Jersey, United States.
- How much did Phibro Animal Health Corporation pay for Zoetis?
- The reported deal value is $350 million.
- What does Phibro Animal Health Corporation do?
- Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company.
- Where are Phibro Animal Health Corporation and Zoetis based?
- Phibro Animal Health Corporation is based in Teaneck, New Jersey, United States. Zoetis is based in Parsippany, New Jersey, United States.
- Who are the decision-makers at Phibro Animal Health Corporation?
- Fundz holds 1 contact at Phibro Animal Health Corporation. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Animal Feed and Pet
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Zinzino acquires assets in Xelliss - strategic reinforcement in southern Europe and in the microalgae spirulina (May 12, 2024)
- Eli Lilly and Company acquires manufacturing facility from Nexus Pharmaceuticals to expand U.S. capacity (April 22, 2024)
- Swifto Expands into North Carolina with Acquisition of Wagz 'n Whiskerz (April 17, 2024)
- Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions, $13B (April 5, 2024)
- Reverba completes acquisition of Six Degrees Worldwide Inc. to integrate medical communication services (April 3, 2024)
- KARL STORZ SE & Co. KG announces non-binding acquisition proposal and exclusivity arrangement with Asensus Surgical, Inc. (April 3, 2024)
Who to call at Phibro Animal Health Corporation, and when
When Phibro Animal Health Corporation changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Phibro Animal Health Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Phibro Animal Health Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Phibro Animal Health Corporation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Phibro Animal Health Corporation makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Zoetis?
Zoetis was acquired by Phibro Animal Health Corporation, based in Teaneck. The deal was reported on April 28, 2024. Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. Phibro Animal Health Corporation is publicly traded (PAHC) and operates in Health Care.
When did Phibro Animal Health Corporation acquire Zoetis?
Phibro Animal Health Corporation's acquisition of Zoetis was reported on April 28, 2024. Phibro Animal Health Corporation has entered into a definitive agreement to acquire Zoetis Inc.’s medicated feed additive (MFA) product portfolio, certain water soluble products, and related assets for $350 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Zoetis do?
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. It is publicly traded (ZTS), operating in Biotechnology, and is based in Parsippany.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.